Association of CYP2B6 and OPRM1 Genotypes with Methadone Dose Requirements and Serum Concentrations in a Vietnamese Cohorts
References
- Intishar K, Meghan JC, Didier JA, Keith A, María Eugenia S, Bernard Le F, Rachel FT. Pharmacogenetics of Biochemically Verified Abstinence in an Opioid Agonist Therapy Randomized Clinical Trial of Methadone and Buprenorphine/Naloxone. Clinical Pharmacology & Therapeutics. 2023;115(3):506–514. doi:10.1002/cpt.3112
- Evan DK, Karen JR, Jane B, Christina F. Methadone Pharmacogenetics: CYP2B6 Polymorphisms Determine Plasma Concentrations, Clearance, and Metabolism. Anesthesiology. 2015;123(5):1142–1153. doi:10.1097/ALN.0000000000000867
- Hsin-Chou Y, Shih-Kai C, Shih-Kai C, et al. Genome-Wide Pharmacogenomic Study on Methadone Maintenance Treatment Identifies SNP rs17180299 and Multiple Haplotypes on CYP2B6, SPON1, and GSG1L Associated with Plasma Concentrations of Methadone R- and S-enantiomers in Heroin-Dependent Patients. PLOS Genetics. 2016;12(3) doi:10.1371/JOURNAL.PGEN.1005910
- Fitri Fareez R. Pharmacogenomics biomarkers for personalized methadone maintenance treatment: The mechanism and its potential use. Bosnian Journal of Basic Medical Sciences. 2020;21(2):145–154. doi:10.17305/BJBMS.2020.4897
- Xiaohui X, Jun G, Dingding Z, et al. Association between rs1799971 in the mu opioid receptor gene and methadone maintenance treatment response. Journal of Clinical Laboratory Analysis. 2022;36(11) doi:10.1002/jcla.24750
- Sabina M, Rajabu Hussein M, Anna Alphonce S, et al. CYP2B6 and ABCB1 genotypes predict methadone plasma exposure among patients on maintenance therapy against opioid addictions in Tanzania. British Journal of Clinical Pharmacology. 2024;doi:10.1111/bcp.16173
- Fatemeh C, Lars Thore F, Kjell Arne J, et al. Methadone pharmacokinetics in opioid agonist treatment: Influencing factors and clinical implications. Basic & Clinical Pharmacology & Toxicology. 2023;doi:10.1111/bcpt.13975
- Andrew HT, Yuxin D, Charles SV, et al. Toward precision prescribing for methadone: Determinants of methadone deposition. PLOS ONE. 2020;15(4) doi:10.1371/JOURNAL.PONE.0231467
- Shuki Y, Eiji H, Yuma S, et al. Functional significance of CYP2B6 gene rare allelic variants identified in Japanese individuals. Biochemical Pharmacology. 2024;229:116515–116515. doi:10.1016/j.bcp.2024.116515
- Sheng-Chang W, Ing-Kang H, Hsiao-Hui T, et al. CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer. Journal of Clinical Psychopharmacology. 2011;31(4):463–469. doi:10.1097/JCP.0B013E318222B5DD
- Yen-Jung C, Ju-Ting L, Chun-Wei H, Wei-Hsin W, Kuei-Fang L, Hsin-Tzu L, Lawrence Shih-Hsin W. Pharmacogenetic study of methadone treatment for heroin addiction: associations between drug-metabolizing gene polymorphisms and treatment efficacy. Pharmacogenetics and Genomics. 2022;32(1):31–38. doi:10.1097/FPC.0000000000000450
- David T, Britt ID, Galen EBW, et al. Characterisation of CYP2B6 and CYP2A6 pharmacogenetic variation in sub-Saharan African populations. Kliničeskaâ farmakologiâ i terapiâ. 2023;doi:10.1002/cpt.3124
- Bunten H, Wei-Jun L, Derrick JP, Collin S, Osselton D. OPRM1 and CYP2B6 gene variants as risk factors in methadone-related deaths. Clinical Pharmacology & Therapeutics. 2010;88(3):383–389. doi:10.1038/CLPT.2010.127
- Chin-Chuan H, Mu-Han C, Bo-Hau H, Yow-Wen H, Tsung-Jen H, Chieh-Liang H, Hsien-Yuan L. Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients. Pharmacogenomics. 2011;12(11):1525–1533. doi:10.2217/PGS.11.96
- Sadat Aghabozorg Afjeh S, Boshehri B, Hamednia S, Amini A, Mashayekhi P, Omrani MD. Investigating the CYP2B6 rs3745274 and rs3211371 polymorphisms in Methadone-Responder and Non-Responder Addicts in Iran. Iran Biomed J. Feb 6 2021;25(3):220–5. doi:10.29252/ibj.25.3.220
- Bunten H, Wei-Jun L, Derrick JP, Collin S, Osselton D. Interindividual variability in the prevalence of OPRM1 and CYP2B6 gene variations may identify drug-susceptible populations. Journal of Analytical Toxicology. 2011;35(7):431–437. doi:10.1093/ANATOX/35.7.431
- Sarah G, Christina F, Evan DK. Differences in Methadone Metabolism by CYP2B6 Variants. Drug Metabolism and Disposition. 2015;43(7):994–1001. doi:10.1124/DMD.115.064352
- Maria D, Séverine C, Beatrice O, et al. Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels: a CYP2B6 gene resequencing study. Pharmacogenetics and Genomics. 2013;23(2):84–93. doi:10.1097/FPC.0B013E32835CB2E2
- Chantal C, Séverine C, Monia G, Chin BE. Population Genetic-Based Pharmacokinetic Modeling of Methadone and its Relationship with the QTc Interval in Opioid-Dependent Patients. Clinical Pharmacokinectics. 2016;55(12):1521–1533. doi:10.1007/S40262-016-0415-2
- Xueying Z, Yongxin L, Nannan Z, et al. The Relevance of the OPRM1 118A>G Genetic Variant for Opioid Requirement in Pain Treatment: A Meta-Analysis. Pain Physician. 2019;22(4):331–340. doi:10.36076/PPJ/2019.22.331
- Miho T, Kazuyuki N, Yoshiaki O, Tomohiro K, Makie K, Yoshinobu M, Kenji I. Comparison of the effects of OPRM1 A118G polymorphism using different opioids: A prospective study. Journal of Pain and Symptom Management. 2023;doi:10.1016/j.jpainsymman.2023.09.017
- Andrew HS, Kevin PJ, Jin L, et al. Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1. Molecular Psychiatry. 2017;22(3):346–352. doi:10.1038/MP.2016.257
- Kelly ED, Andrew SH, Patrick HF, et al. Polymorphisms in the A118G SNP of the OPRM1 gene produce different experiences of opioids: A human laboratory phenotype–genotype assessment. Addiction Biology. 2023;doi:10.1111/adb.13355
- Yihan X, Julie AB. Neural network connectivity following opioid dependence is altered by a common genetic variant in the mu-opioid receptor,OPRM1A118G. The Journal of Neuroscience. 2023;doi:10.1523/jneurosci.1492-23.2023
DOI: https://doi.org/10.2478/bjmg-2025-0010 | Journal eISSN: 2199-5761
Language: English
Published on: Oct 8, 2025
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 times per year
Keywords:
Related subjects:
© 2025 Quynh Giao Nguyen, Khanh Chi Tran, Thi Phuong Dung Trinh, Huy Tan Pham, Thi Ngoc Dung Dang, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.